Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Catridecacog> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Catridecacog abstract "Catridecacog (brand name Tretten in the US and NovoThirteen in Europe) is a class of recombinant factor XIII A-subunit based biopharmaceutical medicine, indicated in patients with a rare clotting disorder, congenital factor XIII A-subunit deficiency, which is a kind of Factor XIII deficiency. The medication prevents bleeding in patients with this condition, and has been approved by the U.S. Food and Drug Administration (FDA) for this use in the US in 2014. It was brought to market by Novo Nordisk.".
- Catridecacog wikiPageID "41867774".
- Catridecacog wikiPageLength "3178".
- Catridecacog wikiPageOutDegree "10".
- Catridecacog wikiPageRevisionID "679795782".
- Catridecacog wikiPageWikiLink Biopharmaceutical.
- Catridecacog wikiPageWikiLink Category:Antihemorrhagics.
- Catridecacog wikiPageWikiLink Category:Biopharmaceuticals.
- Catridecacog wikiPageWikiLink Expert_Opin_Investig_Drugs.
- Catridecacog wikiPageWikiLink Expert_Opinion_on_Investigational_Drugs.
- Catridecacog wikiPageWikiLink Factor_XIII.
- Catridecacog wikiPageWikiLink Factor_XIII_deficiency.
- Catridecacog wikiPageWikiLink Food_and_Drug_Administration.
- Catridecacog wikiPageWikiLink J_Blood_Med..
- Catridecacog wikiPageWikiLink Novo_Nordisk.
- Catridecacog wikiPageWikiLink Recombinant_DNA.
- Catridecacog wikiPageWikiLinkText "Catridecacog".
- Catridecacog wikiPageWikiLinkText "catridecacog".
- Catridecacog drugName "Catridecacog".
- Catridecacog hasPhotoCollection Catridecacog.
- Catridecacog tradename "Tretten, NovoThirteen".
- Catridecacog wikiPageUsesTemplate Template:Cite_journal.
- Catridecacog wikiPageUsesTemplate Template:Infobox_drug.
- Catridecacog wikiPageUsesTemplate Template:Pharma-stub.
- Catridecacog wikiPageUsesTemplate Template:Reflist.
- Catridecacog subject Category:Antihemorrhagics.
- Catridecacog subject Category:Biopharmaceuticals.
- Catridecacog hypernym Subunit.
- Catridecacog type ChemicalSubstance.
- Catridecacog type Drug.
- Catridecacog type Protein.
- Catridecacog type ChemicalObject.
- Catridecacog type Thing.
- Catridecacog type Q8386.
- Catridecacog comment "Catridecacog (brand name Tretten in the US and NovoThirteen in Europe) is a class of recombinant factor XIII A-subunit based biopharmaceutical medicine, indicated in patients with a rare clotting disorder, congenital factor XIII A-subunit deficiency, which is a kind of Factor XIII deficiency. The medication prevents bleeding in patients with this condition, and has been approved by the U.S. Food and Drug Administration (FDA) for this use in the US in 2014.".
- Catridecacog label "Catridecacog".
- Catridecacog sameAs カトリデカコグ.
- Catridecacog sameAs m.0_lfzj1.
- Catridecacog sameAs Q16858452.
- Catridecacog sameAs Q16858452.
- Catridecacog wasDerivedFrom Catridecacog?oldid=679795782.
- Catridecacog isPrimaryTopicOf Catridecacog.